C-ROSS: Preparing for Solvency II with Chinese Characteristics

Create a vendor selection project & run comparison reports
Click to express your interest in this report
Indication of coverage against your requirements
A subscription is required to activate this feature. Contact us for more info.
Celent have reviewed this profile and believe it to be accurate.
19 August 2014

REPORT PREVIOUSLY PUBLISHED BY OLIVER WYMAN

Abstract

The Chinese insurance industry is one of the largest in the world and is growing fast. It is also an industry undergoing immense change, driven by economic growth, consumer demand and an active regulator. C-ROSS is the Chinese equivalent of Solvency II: a modern, risk-based regulatory capital framework which is expected to go into effect in 2015. In this article we identify some of the strategic opportunities and challenges C-ROSS presents to the industry and provide a recommended action plan for senior management. We also compare C-ROSS with Solvency II and consider some of the “Chinese characteristics” of the draft regulations.

Subscription required

Access to this content requires a Celent research subscription.

Subscribers should sign in to access this research.

Insight details

Content Type
Reports
Focus
Risk Management & Compliance
Location
Asia-Pacific